BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22946827)

  • 1. The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals and controls with the TB antigens ESAT-6, CFP-10 and TB7.7.
    Kim SY; Park MS; Kim YS; Kim SK; Chang J; Lee HJ; Cho SN; Kang YA
    Scand J Immunol; 2012 Dec; 76(6):580-6. PubMed ID: 22946827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
    Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
    Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals.
    Martinez V; Carcelain G; Badell E; Jouan M; Mauger I; Sellier P; Truffot C; Bricaire F; Arend SM; Ottenhoff T; Autran B; Gicquel B
    BMC Infect Dis; 2007 Jul; 7():83. PubMed ID: 17655752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
    Kim S; Lee H; Kim H; Kim Y; Cho JE; Jin H; Kim DY; Ha SJ; Kang YA; Cho SN; Lee H
    J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong purified protein derivative responses are associated with poor mycobacterium inhibition in latent TB.
    Kang JS; Cherian A; Gan SH; Lee TH; Lee KC; Chee CB; Doherty TM; Wang YT; Seah GT
    Eur Respir J; 2010 Aug; 36(2):348-54. PubMed ID: 19996195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
    Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
    Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
    Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
    Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
    Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
    J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnicity-tailored novel set of ESAT-6 peptides for differentiating active and latent tuberculosis.
    Singh SB; Biswas D; Rawat J; Sindhwani G; Patras A; Devrani S; Sarkar P; Mitra S; Gupta SK
    Tuberculosis (Edinb); 2013 Nov; 93(6):618-24. PubMed ID: 24011630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
    Oztürk N; Sürücüoğlu S; Ozkütük N; Gazi H; Akçali S; Köroğlu G; Ciçek C
    Mikrobiyol Bul; 2007 Apr; 41(2):193-202. PubMed ID: 17682705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting.
    Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; Matchett E; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
    Tuberculosis (Edinb); 2019 Jan; 114():91-102. PubMed ID: 30711163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.